Literature DB >> 12971621

Organogenesis of heart-vascular system derived from mouse 2 cell stage embryos and from early embryonic stem cells in vitro.

Isamu Ishiwata1, Tomoharu Tamagawa, Yuko Tokieda, Megumi Iguchi, Kahei Sato, Hiroshi Ishikawa.   

Abstract

Regenerative medical treatment with embryonic stem cells (an ES cell) is a goal for organ transplantation. Structures that are tubular in nature (i.e. blood capillaries) were induced from early embryonic stem (EES) cells in vitro using embryotrophic factor (ETFs). In addition, cardiac muscle cells could be identified as well. However, differentiation of EES cells into a complete cardiovascular system was difficult because 3 germ layer primordial organs are directed embryologically in various ways and it is not possible to guide only cardiovascular organs. Thus, we introduced ETFs after the formation of an embryoid body and were successful in cloning cell clusters that beat, thus deriving only cardiovascular organs. The application of this to the treatment of various cardiovascular diseases is promising.

Entities:  

Mesh:

Year:  2003        PMID: 12971621     DOI: 10.1111/j.1749-0774.2003.tb00124.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  11 in total

1.  Effects of embryotrophic factors on the embryogenesis and organogenesis of mouse embryos in vitro.

Authors:  I Ishiwata; Y Tokieda; K Kiguchi; K Sato; H Ishikawa
Journal:  Hum Cell       Date:  2000-12       Impact factor: 4.174

2.  Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats.

Authors:  Jiang-Yong Min; Yinke Yang; Kimber L Converso; Lixin Liu; Qin Huang; James P Morgan; Yong-Fu Xiao
Journal:  J Appl Physiol (1985)       Date:  2002-01

3.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

Authors:  M G Klug; M H Soonpaa; G Y Koh; L J Field
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Effects of feeder cells (human cancer cell lines) on the development of mouse embryos by co-culture.

Authors:  I Ishiwata; Y Tokieda; C Ishiwata; N Okane; M Iguchi; K Sato; H Ishikawa
Journal:  Hum Cell       Date:  1997-12       Impact factor: 4.174

5.  Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium.

Authors:  G Y Koh; M H Soonpaa; M G Klug; L J Field
Journal:  Am J Physiol       Date:  1993-05

6.  Cardiomyocyte transplantation improves heart function.

Authors:  R K Li; Z Q Jia; R D Weisel; D A Mickle; J Zhang; M K Mohabeer; V Rao; J Ivanov
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

7.  Autologous transplantation of bone marrow cells improves damaged heart function.

Authors:  S Tomita; R K Li; R D Weisel; D A Mickle; E J Kim; T Sakai; Z Q Jia
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

Review 8.  New approach for the establishment of mouse early embryonic stem cells and induction of their differentiation.

Authors:  I Ishiwata; Y Tokeida; M Iguchi; C Ishiwata; K Kiguchi; S Yasumoto; K Sato; T Tachibana; H Hashimoto; H Ishikawa
Journal:  Hum Cell       Date:  2001-12       Impact factor: 4.174

9.  Cardiomyocytes can be generated from marrow stromal cells in vitro.

Authors:  S Makino; K Fukuda; S Miyoshi; F Konishi; H Kodama; J Pan; M Sano; T Takahashi; S Hori; H Abe; J Hata; A Umezawa; S Ogawa
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

10.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

View more
  1 in total

1.  Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro.

Authors:  Tomoharu Tamagawa; Isamu Ishiwata; Shigeo Saito
Journal:  Hum Cell       Date:  2004-09       Impact factor: 4.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.